Whole genome sequencing of bacterial isolates of special interest: salmonella, E. Coli, listeria and campylobacter project summary bacteria from animal origin are a major source of food and feed…

Active Cooperative Agreement Awarded

Award ID
U18FD008944
Recipient
Awarding agency
Obligated
$85,499

Award facts

Assistance listing
93.103 Food and Drug Administration Research
Completion date 18% complete
Funding agency
Center for Veterinary Medicine Food and Drug Administration, Department of Health and Human Services
Place of performance
Lauderdale, MN 55108, USA

Award details come from USAspending.gov.

Description

Whole genome sequencing of bacterial isolates of special interest: salmonella, E. Coli, listeria and campylobacter project summary bacteria from animal origin are a major source of food and feed contamination and are often identified as the potential cause of disease on animal or public health disease investigations. The veterinary laboratory investigation and response network (VET-LIRN) has identified the need to improve the bacterial genome information publicly available for several bacterial species, including salmonella SP., E. Coli, listeria SP. And campylobacter SP. We propose to sequence and publish the whole genome of bacteria of special interest for animal and public health. Specifically, this project will focus on salmonella SP., E. Coli, listeria SP. And campylobacter SP. The minnesota veterinary diagnostic laboratory (MVDL) maintains a large collection of isolates from the previous 2 years frozen at -80 C, including more than 1,000 salmonella isolates, more than 1,000 E. Coli isolates and a small number of listeria SP. And campylobacter SP. Isolates. We will select 50 salmonella SP. Isolates and 50 E. Coli isolates to sequence based on their antimicrobial resistance patterns, serotyping information and representativeness. In addition, we will sequence 20 listeria isolates and 20 campylobacter isolates. Bacterial whole genome sequencing will be performed by long read sequencing on an oxford nanopore technology (ONT) sequencing platform. Briefly, bacterial isolates will be resuspended, DNA will be extracted and ONT's ligation-based library preparation will be performed. We will use minion/gridion R10 flow cells run on a gridion sequencer for 12-24 H. In the case that complete genomes could not be assembled with just ONT sequencing, the MVDL has the capability to sequence bacterial isolates by short read sequencing using illumina and element biosciences platforms. Bacterial whole genomes will be assembled from raw reads using assemblers fly and autocycler. Sequencing will be performed to target a minimum genome depth of 30X. Raw sequencing reads and assembled genomes will be deposited in public databases, along with relevant metadata. Antimicrobial resistance prediction based on the antimicrobial genes found in each genome will be compared to the phenotypic antimicrobial resistance information available for each isolate. Genomes that show disagreements between genomic and phenotypic predicted antimicrobial resistance will be further investigated for potential new mechanisms of resistance.

Quick answers

Who received award U18FD008944?

U18FD008944 was awarded to Regents Of The University Of Minnesota by FDA Office of Acquisition and Grant Services (Food and Drug Administration) on September 23, 2026.

How much is award U18FD008944 worth?

$85,499 has been obligated on U18FD008944.

Which agency awarded U18FD008944?

FDA Office of Acquisition and Grant Services (Food and Drug Administration) awarded U18FD008944, with funding from Center for Veterinary Medicine (Food and Drug Administration).

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award